The first 9 Meters Biopharma trade was made in Q1 2021.
Since then Ken Griffin bought shares three more times and sold shares on six occasions. The investor completely sold their stake between Q1 2023 and Q3 2023.
Avg closing price
Price range
Sold -1.39k shares
Q3 2023
Avg closing price
$0.47
Price range
$0.07
-
$0.68
Sold 9.8% shares (-151 shares)
Q1 2023
Avg closing price
$1.89
Price range
$1.31
-
$2.61
Increased shares by 10.7% (+149 shares)
Q4 2022
Avg closing price
$2.28
Price range
$1.00
-
$4.70
New holding (+1.39k shares)
Q3 2022
Avg closing price
$4.96
Price range
$4.14
-
$6.30
Sold -2.01k shares
Q2 2022
Avg closing price
$9.42
Price range
$5.22
-
$12.82
Sold 64.2% shares (-3.59k shares)
Q1 2022
Avg closing price
$13.66
Price range
$10.44
-
$20.00
Sold 40.6% shares (-3.82k shares)
Q4 2021
Avg closing price
$22.37
Price range
$17.00
-
$26.60
Increased shares by 128.1% (+5.29k shares)
Q3 2021